About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
MF HOLDINGS
MF
Holdings
Glaxosmithkline Pharmaceuticals Ltd.
BSE Code
500660
ISIN Demat
INE159A01016
Book Value
98.85
NSE Code
GLAXO
Dividend Yield %
1.40
Market Cap
387008.08
P/E
57.86
EPS
39.49
Face Value
10
Scheme Name
Market Val (In Crs.)
AUM(In Crs.)
Hold Percentage
Aditya Birla SL ELSS Tax Saver Fund(IDCW)
262.21
17102.07
1.53
Kotak Equity Opp Fund(G)
261.30
26175.17
1.00
Nippon India Pharma Fund(G)
229.06
8768.67
2.61
Quant Mid Cap Fund(G)
228.24
9500.7
2.40
SBI Magnum Midcap Fund-Reg(G)
221.94
22338.38
0.99
Nippon India Growth Fund(G)
153.76
35208.97
0.44
Aditya Birla SL MNC Fund-Reg(G)
131.76
4180.08
3.15
Kotak Flexicap Fund(G)
109.84
53844.12
0.20
Bandhan ELSS Tax Saver Fund-Reg(G)
74.26
7353.93
1.01
Quant Large & Mid Cap Fund(G)
62.16
3827.97
1.62
Edelweiss Balanced Advantage Fund-Reg(G)
38.49
12689.91
0.30
Baroda BNP Paribas Mid Cap Fund-Reg(G)
34.38
2247.38
1.53
Quant Healthcare Fund-Reg(G)
27.78
453.77
6.12
Kotak Manufacture in India Fund-Reg(G)
27.51
2617.97
1.05
Helios Flexi Cap Fund-Reg(G)
23.21
2054.02
1.13
Kotak ESG Exclusionary Strategy Fund-Reg(G)
20.63
1023.3
2.02
Bandhan Multi Cap Fund-Reg(G)
20.63
2541.41
0.81
Samco Flexi Cap Fund-Reg(G)
19.27
655.6
2.94
Axis Quant Fund-Reg(G)
18.50
1170.94
1.58
Mahindra Manulife Business Cycle Fund-Reg(G)
13.75
1199.71
1.15
Page
1
of
4
Prev
||
Next
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.